Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001714899-24-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | 2024-08-13 | DNLI | Ho Carole | Chief Medical Off | S - Sale | $22.89 | -2,337 | 141.3K | -2% | -$53.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-13 | S | D | 2,337 | $22.89 | 141,268 | D | — | — | (F2) Includes 123,810 RSUs. |